Long-term immunogenicity of inactivated and oral polio vaccines: an Italian retrospective cohort study

AMV Larocca, FP Bianchi, A Bozzi, S Tafuri… - Vaccines, 2022 - mdpi.com
Oral and inactivated poliovirus (PV) vaccines have contributed toward the global eradication
of wild PV2 and PV3, as well as the elimination of PV1 in most countries. While the long-term …

Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in …

X Tang, Y Xiao, X Deng, Y Zhou, H Chen… - The Lancet Regional …, 2023 - thelancet.com
Background Sabin inactivated and bivalent oral poliovirus vaccine (sIPV, bOPV) were
commonly used in China since 2016. We conducted an open-label, randomised, controlled …

[HTML][HTML] Why have cVDPV2 outbreaks increased globally after the polio immunization strategy switch: challenges for the polio eradication endgame

H Wang - China CDC Weekly, 2020 - ncbi.nlm.nih.gov
Since the World Health Assembly (WHA) set the goal of polio eradication in 1988, the Global
Polio Eradication Initiative (GPEI) has reduced the global incidence of polio by more than …

[HTML][HTML] Battle of Polio eradication in the Western Pacific Region in the transition to COVID-19 endemicity

R Mei, SLL Kwok, EHY Lau, THK Lo, JT Wu… - The Journal of …, 2023 - ncbi.nlm.nih.gov
Dear Editor, We have read with great interest a letter published in this journal entitled “The
emergence of mumps after the COVID-19 pandemic in Pakistan: Time to consider MMR …

Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination

Z Yu-Ping, L Jing, H Teng, Y Zhi-Fang, Z Ting… - npj Vaccines, 2023 - nature.com
To provide a basis for further optimization of the polio sequential immunization schedule,
this study evaluated the effectiveness of booster immunization with one dose of bivalent oral …

[HTML][HTML] Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ …

Q Yin, Y Zheng, Z Ying, J Li, Y Jiang, W Bao, Y Dou… - Vaccine, 2024 - Elsevier
Background There has been no data on the immunogenicity and safety of the 4 th booster
dose of the sIPV immunization in 18–24 months old children in post-marketing studies of …

Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with …

G Kang, F Tang, Z Wang, R Hu, J Yu… - Human Vaccines & …, 2021 - Taylor & Francis
One dose of inactivated poliovirus vaccine (IPV) was introduced into the Chinese Expanded
Program on Immunization (EPI) in 2016. IPV made from Sabin strains (sIPV) was newly …

Safety evaluation on concomitant immunization with inactivated poliomyelitis vaccine produced from Sabin strains and other vaccines (from 2015 to 2020)

Y Deng, L Yi, Y Li, Z Zhao, Z Zhong, H Shi… - Human Vaccines & …, 2022 - Taylor & Francis
Objective To evaluate the safety of concomitantly administering inactivated poliomyelitis
vaccine produced from Sabin strains (sIPVs) with other vaccines. Methods A descriptive …

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: an open-label, randomized, controlled trial

Y Wang, Q Xu, V Jeyaseelan, Z Ying… - The Lancet Regional …, 2021 - thelancet.com
Background We assessed immunogenicity of three-dose and two-dose immunization
schedules with a Sabin-strain inactivated poliovirus vaccine (sIPV) produced by one …

Adverse events following immunization with bivalent oral poliovirus vaccine in Jiangsu, China

J Gao, G Kang, R Hu, L Zhang, J Yu… - British journal of …, 2021 - Wiley Online Library
Aims The bivalent oral poliovirus vaccine (bOPV; Sabin types 1 and 3) replaced the trivalent
OPV (Sabin types 1, 2 and 3) globally in April 2016. A routine schedule of 1 dose of …